NADPH and Mitochondrial Quality Control as Targets for a Circadian-Based Fasting and Exercise Therapy for the Treatment of Parkinson's Disease.
Level 5 - mechanism / opinion, no new human data
Narrative review presenting mechanistic reasoning and theoretical proposals with no new empirical data.
PubMed 35954260 · doi:10.3390/cells11152416
What was done
This paper is a narrative review and theoretical synthesis evaluating how circadian-timed intermittent fasting and morning exercise might address mitochondrial quality control deficits in Parkinson's disease. The authors synthesized molecular pathways involving ketone body ((R)-3-hydroxybutyrate) metabolism, isocitrate dehydrogenase 1 flux, NADPH regulation, and PINK1-dependent mitophagy.
What was found
The abstract reports no empirical data or statistical results. It outlines a mechanistic hypothesis wherein intermittent fasting (from evening dinner until the following day's lunch) combined with morning exercise aligns with daily circadian peaks in oxidized NAD+/NADH, reduced NADP+/NADPH, and mitophagy gene expression to enhance mitochondrial clearance and protect against oxidative and proteotoxic stress.
Why it matters
It establishes a biological rationale for chronobiological lifestyle interventions in neurodegenerative diseases, offering a specific fasting and exercise schedule that could be evaluated in clinical trials for Parkinson's disease.
Limits
The paper presents no original clinical or experimental data. The therapeutic model rests entirely on theoretical mechanisms and extrapolations from preclinical biochemistry; clinical safety, adherence, and actual efficacy in slowing Parkinson's disease progression are unmeasured.
Cited by
- supports Ketones act as signaling molecules that prompt mitochondria to repair themselves and undergo mitogenesis.